| Revision as of 11:02, 17 February 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{chembox}} taken from revid 399496465 of page Allylescaline for the Chem/Drugbox validation project (updated: 'ChEMBL', 'ChemSpiderID', 'StdInChI', 'StdInChIKey', 'CASNo'). |
Latest revision as of 14:56, 14 October 2024 edit Nonyabozz (talk | contribs)1 editm Removed "Seeing pink elephants."Tag: Manual revert |
| Line 1: |
Line 1: |
|
|
{{Short description|Psychedelic drug}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{chembox |
|
{{chembox |
|
|
| Verifiedfields = changed |
| ⚫ |
| verifiedrevid = 399495504 |
|
|
|
| Watchedfields = changed |
| ⚫ |
| ImageFile1 = AL-PEA.png |
|
|
⚫ |
| verifiedrevid = 477348333 |
|
⚫ |
| ImageFile1 = Allylescaline.svg |
|
| ImageSize1 = 200px |
|
| ImageSize1 = 200px |
|
| ImageFile2 = Allylescaline-3d-sticks.png |
|
| ImageFile2 = Allylescaline-3d-sticks.png |
|
| ImageSize2 = 200px |
|
| ImageSize2 = 200px |
|
|
| PIN = 2-<nowiki/>{3,5-Dimethoxy-4-phenyl}ethan-1-amine |
|
| IUPACName = 2-(4-Allyloxy-3,5-dimethoxy-phenyl)-ethylamine |
|
|
| OtherNames = 4-Allyloxy-3,5-dimethoxyphenethylamine<br>4-Allyloxy-3,5-dimethoxy-1-ethylamine |
|
| OtherNames = 2-ethan-1-amine<br />2-ethanamine |
|
| Section1 = {{Chembox Identifiers |
|
|Section1={{Chembox Identifiers |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
| ChemSpiderID = 13835977 |
|
| ChemSpiderID = 21106254 |
|
| InChI = 1/C13H19NO3/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h4,8-9H,1,5-7,14H2,2-3H3 |
|
| InChI = 1/C13H19NO3/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h4,8-9H,1,5-7,14H2,2-3H3 |
|
| InChIKey = JNUAYHHGCXYBHX-UHFFFAOYAR |
|
| InChIKey = JNUAYHHGCXYBHX-UHFFFAOYAR |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|
| StdInChI = 1S/C3H7N/c1-2-3-4/h2H,1,3-4H2 |
|
| StdInChI = 1S/C13H19NO3/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h4,8-9H,1,5-7,14H2,2-3H3 |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|
| StdInChIKey = VVJKKWFAADXIJK-UHFFFAOYSA-N |
|
| StdInChIKey = JNUAYHHGCXYBHX-UHFFFAOYSA-N |
|
|
| CASNo_Ref = {{cascite|correct|CAS}} |
|
| CASNo = 107-11-9 |
|
|
| ChEMBL = 57286 |
|
| CASNo = 39201-75-7 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
| ⚫ |
| PubChem = |
|
|
|
| UNII = J39IWS08EN |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = 126803 |
|
⚫ |
| PubChem = 44719469 |
|
|
| PubChem1 = 71669102 |
|
|
| PubChem1_Comment = hydrochloride |
|
| SMILES = COc1cc(cc(OC)c1OCC=C)CCN |
|
| SMILES = COc1cc(cc(OC)c1OCC=C)CCN |
|
}} |
|
}} |
|
| Section2 = {{Chembox Properties |
|
|Section2={{Chembox Properties |
|
|
| C=13 |
|
| Formula = C<sub>13</sub>H<sub>19</sub>NO<sub>3</sub> |
|
|
|
| H=19 |
|
| MolarMass = 237.29 g/mol |
|
|
|
| N=1 |
|
|
| O=3 |
|
| Appearance = |
|
| Appearance = |
|
| Density = |
|
| Density = |
| Line 30: |
Line 40: |
|
| BoilingPt = |
|
| BoilingPt = |
|
| Solubility = }} |
|
| Solubility = }} |
|
| Section3 = {{Chembox Hazards |
|
|Section3={{Chembox Hazards |
|
| MainHazards = |
|
| MainHazards = |
|
| FlashPt = |
|
| FlashPt = |
|
| Autoignition = }} |
|
| AutoignitionPt = }} |
|
}} |
|
}} |
|
|
|
|
|
'''Allylescaline''' ('''4-allyloxy-3,5-dimethoxyphenethylamine''') is a lesser-known ]. It is closely related in structure to ]. Allylescaline was first synthesized by Otakar Leminger in 1972.<ref>{{cite journal|last=Leminger|first=Otakar|title=The Chemistry of Alkoxylated Phenethylamines – Part 2|journal=Chemický Průmysl|year=1972|volume=22|page=553|url=http://www.erowid.org/archive/rhodium/chemistry/leminger.html}}</ref> The compound was later synthesized by ] and further described in his book '']''.<ref name=PiHKAL></ref> The dosage range is listed as 20–35 mg, and the duration 8–12 hours.<ref name=PiHKAL/> Allylescaline produces an ] warmth, an ]ic effect, and a feeling of flowing energy. Very little data exists about the pharmacological properties, metabolism, and ] of allylescaline. |
|
|
|
|
|
== Legal status == |
|
|
Allylescaline is illegal in Sweden as of January 2016.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/november/31-nya-amnen-kan-klassas-som-narkotika-eller-halsofarlig-vara/ | title=31 nya ämnen kan klassas som narkotika eller hälsofarlig vara | publisher=Folkhälsomyndigheten | language=Swedish | date=November 2015}}</ref> |
|
|
|
|
|
== See also == |
|
|
* ] |
|
|
* ] |
|
|
* ] |
|
|
* ] |
|
|
|
|
|
==References== |
|
|
{{reflist}} |
|
|
|
|
|
== External links == |
|
|
* |
|
|
|
|
|
] |
|
|
] |
|
|
] |
|
|
] |
|
|
|
|
|
|
|
|
{{Psychoactive-stub}} |